The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds

被引:493
作者
Hudson, Sean A. [1 ]
Ecroyd, Heath [1 ,2 ]
Kee, Tak W. [1 ]
Carver, John A. [1 ]
机构
[1] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia
[2] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
amyloid fibril; thioflavin T; congo red; polyphenol; kappa-casein; IN-VITRO; CONGO RED; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; KAPPA-CASEIN; THERAPEUTIC STRATEGIES; PROTEIN AGGREGATION; EXCITED-STATE; BETA-PROTEIN; BOVINE-MILK;
D O I
10.1111/j.1742-4658.2009.07307.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thioflavin T (ThT) dye fluorescence is used regularly to quantify the formation and inhibition of amyloid fibrils in the presence of anti-amyloidogenic compounds such as polyphenols. However, in this study, it was shown, using three polyphenolics (curcumin, quercetin and resveratrol), that ThT fluorescence should be used with caution in the presence of such exogenous compounds. The strong absorptive and fluorescent properties of quercetin and curcumin were found to significantly bias the ThT fluorescence readings in both in situ real-time ThT assays and single time-point dilution ThT-type assays. The presence of curcumin at concentrations as low as 0.01 and 1 mu m was sufficient to interfere with the ThT fluorescence associated with fibrillar amyloid-beta(1-42) (0.5 mu m) and fibrillar reduced and carboxymethylated kappa-casein (50 mu m), respectively. The ThT fluorescence associated with fibrillar amyloid-beta(1-42) was also biased using higher concentrations of resveratrol, a polyphenol that is not spectroscopically active at the wavelengths of ThT fluorescence, implying that there can be direct interactions between ThT and the exogenous compound and/or competitive binding with ThT for the fibrils. Thus, in all cases where ThT is used in the presence of an exogenous compound, biases for amyloid-associated ThT fluorescence should be tested, regardless of whether the additive is spectroscopically active. Simple methods to conduct these tests were described. The Congo red spectral shift assay is demonstrated as a more viable spectrophotometric alternative to ThT, but allied methods, such as transmission electron microscopy, should also be used to assess fibril formation independently of dye-based assays.
引用
收藏
页码:5960 / 5972
页数:13
相关论文
共 53 条
[41]   Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro [J].
Ono, K ;
Hasegawa, K ;
Naiki, H ;
Yamada, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 75 (06) :742-750
[42]   Ferulic acid destabilizes preformed β-amyloid fibrils in vitro [J].
Ono, K ;
Hirohata, M ;
Yamada, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 336 (02) :444-449
[43]   Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro:: implications for the prevention and therapeutics of Alzheimer's disease [J].
Ono, K ;
Yoshiike, Y ;
Takashima, A ;
Hasegawa, K ;
Naiki, H ;
Yamada, M .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (01) :172-181
[44]   Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro [J].
Ono, K ;
Yamada, M .
JOURNAL OF NEUROCHEMISTRY, 2006, 97 (01) :105-115
[45]   Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism [J].
Porat, Y ;
Abramowitz, A ;
Gazit, E .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (01) :27-37
[46]   Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility [J].
Reinke, Ashley A. ;
Gestwicki, Jason E. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2007, 70 (03) :206-215
[47]   Inhibitory activity of stilbenes on Alzheimer's β-amyloid fibrils in vitro [J].
Riviere, Celine ;
Richard, Tristan ;
Quentin, Lysiane ;
Krisa, Stephanie ;
Merillon, Jean-Michel ;
Monti, Jean-Pierre .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (02) :1160-1167
[48]  
Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385
[49]   Therapeutic strategies for human amyloid diseases [J].
Sacchettini, JC ;
Kelly, JW .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :267-275
[50]   SELECTIVE REDUCTION OF CYSTINE I-VIII IN ALPHA-LACTALBUMIN OF BOVINE MILK [J].
SHECHTER, Y ;
PATCHORN.A ;
BURSTEIN, Y .
BIOCHEMISTRY, 1973, 12 (18) :3407-3413